These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 19863058

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Two-dimensional solvent-mediated phase transformation in lipid membranes induced by sphingomyelinase.
    Chao L, Chen F, Jensen KF, Hatton TA.
    Langmuir; 2011 Aug 16; 27(16):10050-60. PubMed ID: 21675765
    [Abstract] [Full Text] [Related]

  • 3. Shape transitions and lattice structuring of ceramide-enriched domains generated by sphingomyelinase in lipid monolayers.
    Härtel S, Fanani ML, Maggio B.
    Biophys J; 2005 Jan 16; 88(1):287-304. PubMed ID: 15489298
    [Abstract] [Full Text] [Related]

  • 4. Lipid raft composition modulates sphingomyelinase activity and ceramide-induced membrane physical alterations.
    Silva LC, Futerman AH, Prieto M.
    Biophys J; 2009 Apr 22; 96(8):3210-22. PubMed ID: 19383465
    [Abstract] [Full Text] [Related]

  • 5. Rapid phase change of lipid microdomains in giant vesicles induced by conversion of sphingomyelin to ceramide.
    Taniguchi Y, Ohba T, Miyata H, Ohki K.
    Biochim Biophys Acta; 2006 Feb 22; 1758(2):145-53. PubMed ID: 16580624
    [Abstract] [Full Text] [Related]

  • 6. Formation of ceramide-enriched domains in lipid particles enhances the binding of apolipoprotein E.
    Morita SY, Nakano M, Sakurai A, Deharu Y, Vertut-Doï A, Handa T.
    FEBS Lett; 2005 Mar 14; 579(7):1759-64. PubMed ID: 15757672
    [Abstract] [Full Text] [Related]

  • 7. Sphingomyelinase induces lipid microdomain formation in a fluid phosphatidylcholine/sphingomyelin membrane.
    Holopainen JM, Subramanian M, Kinnunen PK.
    Biochemistry; 1998 Dec 15; 37(50):17562-70. PubMed ID: 9860872
    [Abstract] [Full Text] [Related]

  • 8. Hemolysis induced by Bacillus cereus sphingomyelinase.
    Oda M, Takahashi M, Matsuno T, Uoo K, Nagahama M, Sakurai J.
    Biochim Biophys Acta; 2010 Jun 15; 1798(6):1073-80. PubMed ID: 20214877
    [Abstract] [Full Text] [Related]

  • 9. Detergent-resistant, ceramide-enriched domains in sphingomyelin/ceramide bilayers.
    Sot J, Bagatolli LA, Goñi FM, Alonso A.
    Biophys J; 2006 Feb 01; 90(3):903-14. PubMed ID: 16284266
    [Abstract] [Full Text] [Related]

  • 10. Tunable nucleation time of functional sphingomyelinase--lipid features studied by membrane array statistic tool.
    Lin CY, Chao L.
    Langmuir; 2013 Oct 22; 29(42):13008-17. PubMed ID: 24059643
    [Abstract] [Full Text] [Related]

  • 11. Bidirectional control of sphingomyelinase activity and surface topography in lipid monolayers.
    Fanani ML, Härtel S, Oliveira RG, Maggio B.
    Biophys J; 2002 Dec 22; 83(6):3416-24. PubMed ID: 12496108
    [Abstract] [Full Text] [Related]

  • 12. Differential regulation of ceramide in lipid-rich microdomains (rafts): antagonistic role of palmitoyl:protein thioesterase and neutral sphingomyelinase 2.
    Goswami R, Ahmed M, Kilkus J, Han T, Dawson SA, Dawson G.
    J Neurosci Res; 2005 Jul 15; 81(2):208-17. PubMed ID: 15929065
    [Abstract] [Full Text] [Related]

  • 13. Surface tension induced by sphingomyelin to ceramide conversion in lipid membranes.
    López-Montero I, Vélez M, Devaux PF.
    Biochim Biophys Acta; 2007 Mar 15; 1768(3):553-61. PubMed ID: 17292325
    [Abstract] [Full Text] [Related]

  • 14. Cholesterol modulation of sphingomyelinase activity at physiological temperatures.
    Contreras FX, Sot J, Ruiz-Argüello MB, Alonso A, Goñi FM.
    Chem Phys Lipids; 2004 Jul 15; 130(2):127-34. PubMed ID: 15172829
    [Abstract] [Full Text] [Related]

  • 15. Full CD3/TCR activation through cholesterol-depleted lipid rafts.
    Rouquette-Jazdanian AK, Pelassy C, Breittmayer JP, Aussel C.
    Cell Signal; 2007 Jul 15; 19(7):1404-18. PubMed ID: 17303381
    [Abstract] [Full Text] [Related]

  • 16. Ceramide promotes restructuring of model raft membranes.
    Johnston I, Johnston LJ.
    Langmuir; 2006 Dec 19; 22(26):11284-9. PubMed ID: 17154617
    [Abstract] [Full Text] [Related]

  • 17. Sphingomyelinase-induced domain shape relaxation driven by out-of-equilibrium changes of composition.
    Fanani ML, De Tullio L, Hartel S, Jara J, Maggio B.
    Biophys J; 2009 Jan 19; 96(1):67-76. PubMed ID: 18849413
    [Abstract] [Full Text] [Related]

  • 18. Sphingomyelinase acts by an area-activated mechanism on the liquid-expanded phase of sphingomyelin monolayers.
    De Tullio L, Maggio B, Fanani ML.
    J Lipid Res; 2008 Nov 19; 49(11):2347-55. PubMed ID: 18509194
    [Abstract] [Full Text] [Related]

  • 19. Ordered-disordered domain coexistence in ternary lipid monolayers activates sphingomyelinase by clearing ceramide from the active phase.
    Ale EC, Maggio B, Fanani ML.
    Biochim Biophys Acta; 2012 Nov 19; 1818(11):2767-76. PubMed ID: 22763279
    [Abstract] [Full Text] [Related]

  • 20. Sphingomyelinase and membrane sphingomyelin content: determinants ofProximal tubule cell susceptibility to injury.
    Zager RA, Burkhart KM, Johnson A.
    J Am Soc Nephrol; 2000 May 19; 11(5):894-902. PubMed ID: 10770967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.